Table IV.

Clinical and angiographic results

MACE (clinical and angiographic)	All patients (n = 187)	Stable patients (n = 158)	Acute patients (n = 29)
Hospital death1	1.1 (2/187)	0.6 (1/158)	3.4 (1/29)
Hospital scaffold thrombosis	0.5 (1/157)	0.6 (1/158)	0
Hospital myocardial infarction	0.5 (1/187)	0.6 (1/158)	0
Lost to follow-up	3.8 (7/187)	1.8 (3/158)	13.7 (4/29)
All-cause death:	3.9 (7/178)	4.4 (7/155)	0
Cancer	1.6 (3/178)	1.9 (3/155)	0
Cerebrovascular	1.1 (2/178)	1.3 (2/155)	0
Unknown	1.1 (2/178)	1.2 (2/155)	0
Myocardial infarction1	1.6 (3/178)	0.6 (1/155)	7.1 (2/25)
Cerebral infarction	1.7 (3/178)	1.9 (3/155)	0
CABG	0	0	0
Major bleeding	1.1 (2/178)	1.3 (2/155)	0
Post-discharge scaffold thrombosis:
Definite	0.5 (1/178)	0.6 (1/155)	0
Possible	0	0	0
Probable	0	0	0
Total scaffold thrombosis	1.1 (2/180)	1.1 (2/180)	0
Angiographic follow-up	46.0 (82/178)	46.4 (72/155)	40.0 (10/25)
Angiographic in-scaffold restenosis	6.0 (5/82)	6.9 (5/72)	0
Restenosis type:
Focal	1.2 (1/82)	1.1 (1/72)	0
Diffuse intra-scaffold	4.8 (4/82)	5.5 (4/72)	0
Treated restenosis	4.8 (4/82)	5.5 (4/72)	0
TLR	3.9 (7/178)	4.5 (7/158)	0
TVR*,2	8.4 (15/178)	7.7 (12/155)	12 (3/25)

Data are presented as percentage of total number (%) and number of patients from total number (n/n-total).

^*Five planned elective PCI, three metal stent restenosis.

¹Non-statistically significant difference between groups.

²Statistically significant difference for TVR between stable and acute patient groups (p < 0.03).